Gilead Sciences, Inc.
PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS
Last updated:
Abstract:
The present disclosure relates to methods and intermediates for the synthesis of certain compounds that inhibit MCL1, for use in the treatment of cancers.
Status:
Application
Type:
Utility
Filling date:
17 Nov 2021
Issue date:
9 Jun 2022